Bioinformatics analysis reveals the potential target of rosiglitazone as an antiangiogenic agent for breast cancer therapy

Background: Several studies have demonstrated the antitumor activity of rosiglitazone (RGZ) in cancer cells, includ- ing breast cancer cells. However, the molecular targets of RGZ in the inhibition of angiogenesis in breast cancer cells remain unclear. This study aimed to explore the potential tar...

全面介紹

Saved in:
書目詳細資料
Main Authors: Hermawan, Adam, Putri, Herwandhani
格式: Article PeerReviewed
語言:English
出版: Springer 2022
主題:
在線閱讀:https://repository.ugm.ac.id/278720/1/Hermawan_FA.pdf
https://repository.ugm.ac.id/278720/
https://bmcgenomdata.biomedcentral.com/articles/10.1186/s12863-022-01086-2
https://doi.org/10.1186/s12863-022-01086-2
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!
機構: Universitas Gadjah Mada
語言: English